A metaproteomic approach to study human-microbial ecosystems at the mucosal luminal interface. by Li, Xiaoxiao et al.
UCLA
UCLA Previously Published Works
Title
A metaproteomic approach to study human-microbial ecosystems at the mucosal luminal 
interface.
Permalink
https://escholarship.org/uc/item/82r070v6
Journal
PloS one, 6(11)
ISSN
1932-6203
Authors
Li, Xiaoxiao
LeBlanc, James
Truong, Allison
et al.
Publication Date
2011
DOI
10.1371/journal.pone.0026542
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
A Metaproteomic Approach to Study Human-Microbial
Ecosystems at the Mucosal Luminal Interface
Xiaoxiao Li1, James LeBlanc2, Allison Truong2, Ravi Vuthoori2, Sharon S. Chen1, Jonathan L. Lustgarten3,
Bennett Roth4, Jeff Allard4, Andrew Ippoliti5, Laura L. Presley6, James Borneman6, William L. Bigbee7,8,
Vanathi Gopalakrishnan3,9, Thomas G. Graeber1,10, David Elashoff10,11,12, Jonathan Braun1,2,10*., Lee
Goodglick2,10*.
1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of
America, 2Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United
States of America, 3Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America, 4Department of Medicine,
Division of Digestive Disease, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America, 5 Inflammatory
Bowel Disease Center, Cedars-Sinai Medical Center, Los Angeles, California, United States of America, 6Department of Plant Pathology and Microbiology, University of
California Riverside, Riverside, California, United States of America, 7Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania,
United States of America, 8University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America, 9Department of
Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America, 10 Jonsson Comprehensive Cancer
Center, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America, 11Department of Medicine, David
Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America, 12Department of Biostatistics, David Geffen School of
Medicine at University of California Los Angeles, Los Angeles, California, United States of America
Abstract
Aberrant interactions between the host and the intestinal bacteria are thought to contribute to the pathogenesis of many
digestive diseases. However, studying the complex ecosystem at the human mucosal-luminal interface (MLI) is challenging
and requires an integrative systems biology approach. Therefore, we developed a novel method integrating lavage
sampling of the human mucosal surface, high-throughput proteomics, and a unique suite of bioinformatic and statistical
analyses. Shotgun proteomic analysis of secreted proteins recovered from the MLI confirmed the presence of both human
and bacterial components. To profile the MLI metaproteome, we collected 205 mucosal lavage samples from 38 healthy
subjects, and subjected them to high-throughput proteomics. The spectral data were subjected to a rigorous data
processing pipeline to optimize suitability for quantitation and analysis, and then were evaluated using a set of biostatistical
tools. Compared to the mucosal transcriptome, the MLI metaproteome was enriched for extracellular proteins involved in
response to stimulus and immune system processes. Analysis of the metaproteome revealed significant individual-related as
well as anatomic region-related (biogeographic) features. Quantitative shotgun proteomics established the identity and
confirmed the biogeographic association of 49 proteins (including 3 functional protein networks) demarcating the proximal
and distal colon. This robust and integrated proteomic approach is thus effective for identifying functional features of the
human mucosal ecosystem, and a fresh understanding of the basic biology and disease processes at the MLI.
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Introduction
The intestinal mucosal surface plays diverse and critical roles in
nutrient uptake, host defense, and local and systemic endocrinol-
ogy [1,2,3,4]. Anatomic regions of the intestine differ in these
properties and their resultant disease susceptibility, in part due to
corresponding differences in the composition and function of
mucosal cell types. However, the functional state of the mucosa in
health and disease is also profoundly affected by its interplay with
luminal intestinal microbiota [5,6]. Molecular phylotypic analysis
has uncovered great complexity and inter-individual heterogeneity
of the organisms comprising the intestinal microbiome [7,8,9].
Accordingly, functional assessment of the microbiome has recently
emphasized metagenomic and biochemical analysis, uncovering
commonalities in metabolic and other traits responsive to diet, and
reciprocal interactions with host physiology [10,11,12,13].
Thus far, such studies have almost exclusively focused on the
biology of the fecal compartment, and there have been only
limited assessments of the mucosal surface itself. Gnotobiotic mice
have delineated extensive, reciprocal adaptive gene expression and
functional change in both colonic mucosal and microbial
populations [14,15], and extensive and unique microbial commu-
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nities have been detected at the human mucosal-luminal interface
(MLI) [7,8]. However, there are few strategies available to directly
analyze the function of the MLI in humans as an integrated host-
commensal biologic unit.
In this study, we introduced a novel approach to directly sample
the MLI by endoscopic saline lavage of the mucosal surface at
multiple anatomic regions in individual patients. High-throughput
proteomic analysis and a suite of bioinformatics tools were utilized
to profile the human mucosal metaproteome represented in these
samples. A schematic flowchart of sample collection and initial
characterization is illustrated in Figure 1. Using this approach, we
found that mucosal lavage specimens contain components of both
human and microbial origin. Comparison of inter- and intra-
subject variation of the mucosal metaproteome found that a
significant feature of the metaproteome is biogeographic, distin-
guishing the distal and proximal colon regions. We used
quantitative shotgun proteomics to further identify host proteins
carrying strong biogeographic features. The results showed that
this new integrated sampling and analytical approach is capable of
analyzing molecular compositions at different locations along the
gastrointestinal tract, and hence provides a new dimension to the
characterization of host-microbial interaction at the human MLI.
Results
Characterizing the phylotypic origin of mucosal lavage
proteins
To study the mucosal luminal interface, we established a novel
protocol to directly examine this environment using samples obtained
by endoscopic lavage. Briefly, 30 ml of sterile saline was injected onto
a discrete surface of the mucosal surface in each colon region. The
wash was then collected by vacuum suction. Based on the live time
imaging from the video camera attached to the colonoscope,
approximately 1 cm2 of the mucosal surface area was thoroughly
rinsed in each lavage procedure. We initially collected 18 mucosal
lavage samples from 6 intestinal regions of 3 healthy individuals
undergoing cancer surveillance colonoscopic screening. Samples
were centrifuged to separate the insoluble components (pellet) from
the supernatant. We first analyzed the 18 cell pellets by cytology with
Gram (Fig. 2a, b) or hematoxylin and eosin (H&E) staining. We
observed 99% of the pellet consisted of bacterial cells. Human cell or
food debris was only rarely observed. The bacteria population was a
mixed population, consisting of both Gram-negative and -positive
organisms with diverse morphological features.
To get a general estimate of the soluble composition of the MLI,
supernatant fractions from the 18 mucosal lavage fluid specimens
were combined, processed, trypsin digested, and analyzed by a
shotgun proteomic approach. We were able to characterize tryptic
peptides from 117 unique proteins in the sample, among which
63% (74) were human proteins, 30% (35) were bacterial, and 9
proteins were from phage or Amoebozoa (Fig. 2c). A list of
identified proteins is provided (Table S1). Among the bacterial
proteins, 48% belonged to the Bacteroidetes, the most abundant
phylum of human intestinal microbiota. We also observed proteins
from other bacterial phyla, including Proteobacteria, Acidobacteria,
Firmicutes, Chlorobi, and Cyanobacteria (Fig. 2d). These findings
demonstrated that mucosal lavage proteins represent a mixture of
host and microbial products.
Profiling the mucosal metaproteome in healthy subjects
To establish a more detailed characterization of the human
mucosal metaproteome, we collected an additional 205 lavage
samples from 38 healthy individuals. Typically, samples from six
different colon regions were collected from the same subject. The
demographics of the study population are summarized in Table 1.
Each lavage sample was pre-processed and analyzed identically by
matrix-assisted laser desorption/ionization (MALDI) time-of-flight
(TOF) mass spectrometry (MS) proteomics in duplicates or
triplicates. In total, 491 MALDI-TOF-MS spectra were collected
from the 205 samples.
High-resolution, high-throughput mass spectrometric proteo-
mics presents a variety of challenges in data pre-processing and
analysis [16]. Also, there are few mature commercially-available
data management platforms, nor widely-accepted standards, for
comprehensive proteomics data management. Therefore, we
established a working protocol for high-resolution MALDI-TOF-
MS data management from inception to final analysis, using
software that is freely downloadable and open-source. The
detailed spectral pre-processing procedure is summarized in
Figure 3a.
To process high-resolution MALDI data, we used a recent
edition of SpecAlign [17]. After pre-processing, 438 protein/
peptide features (‘‘peaks’’) were selected from each metaproteomic
spectrum. Each peak was labeled using the m/z value detected by
MALDI-TOF-MS. In addition, we developed a stringent quality
control protocol to remove outlier spectra. Each spectrum was
inspected individually at two levels: total ion intensity level and
average correlation with the entire dataset. Spectra with both
intensity level and average correlation in the bottom 20% of the
spectral profiles were disqualified, yielding a rate of outliers of
1.2%. Six spectra from two samples failed quality control criteria,
likely due to low protein concentration. The remaining 485
spectrum data from 203 samples were used for subsequent study.
Prior to analyzing the complete set of data, we set out to
characterize the reproducibility and robustness of our strategy.
First, to test the reproducibility of the mucosal lavage sampling
strategy, we collected lavage samples from two adjacent mucosa
sites in the transverse colon. The sampling control replicates
showed similar spectrum and had a correlation of 0.97 (Figure 3b).
This indicated that our sampling strategy was reproducible. To
further assess the reproducibility of sample processing and
instrumental analysis, we also calculated the correlation between
duplicate or triplicate samples. The average correlation coefficient
is 0.99, indicating a high reproducibility of sample processing
(Fig. 3c).
Due to the large number of samples, it was necessary to divide
analysis into several MALDI-TOF-MS runs. This could poten-
tially introduce an instrumental batch-effect noise which would
contribute an artificial variance to our final results [18]. Therefore,
we not only randomized all the samples to 7 batches, but also
included batch control samples in quadruplicates on every 96-well
MALDI-target plate for batch effect assessment. Not surprisingly,
correlation analysis revealed a batch effect, as the intra-batch
average correlation was 0.99, higher than the inter-batch average
correlation 0.96 (Table S2). Therefore, a subsequent step was
included to remove the batch effect before further analysis [19].
To adjust for batch effects in nucleotide microarray data, the
empirical Bayes framework has proven robust for both large and
small sample size. We adopted this strategy and performed similar
adjustment on our MALDI-TOF-MS spectral data. After
correction, the batch effect was no longer a predominant source
of variance in the data, thus allowing us to characterize biological
variations and similarities.
Determining individual and biogeographic-related
features of metaproteome
After pre-processing, the metaproteome dataset containing 438
peaks from 203 samples was analyzed by a number of biostatistical
Protein Neighborhoods of the Mucosal Interface
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methods (Dataset S1). First, to gain an overview of the source of
variance in the human mucosal metaproteome, we conducted a
principal variance component analysis. We first used a common
multivariate method, Principal Component Analysis (PCA), to
reduce the dimensions of the variance. This analysis revealed the
first component (PC1) accounts for 34.4% of the total variance in
the data (Fig. 4a). Second, we performed variance component
analysis using a non-linear mixed-effect model (NLME) on PC1
specifically [20]. This analysis revealed that inter-subject (individ-
ual) factors contributed the majority of the variance. However,
within each individual, there was a 5% biological variance among
regions of the colon (referred to as ‘intra-subject, biogeographic
factor’) (Fig. 4b). Consistent with other metagenomic data [7], the
inter-subject difference was more predominant than the intra-
subject level.
Next, we further examined the significance of the intra-subject
biogeographic feature. Because of the hierarchical structure of the
variation resources, we used the NLME model to compensate for
Figure 1. Flowchart of mucosal lavage sampling.
doi:10.1371/journal.pone.0026542.g001
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individual factor. We analyzed the metaproteomic data to find
peaks with differential abundance across the 6 colon anatomic
regions. We then calculated the P-value which indicates the
significance of the biogeographic feature for each peak (Table S3),
and tabulated all 438 P-values on a frequency plot. If the effect was
a random observation, less than 5% of the total peaks would have
P-values smaller than 0.05. Instead, we observed a non-uniform
distribution with over 25% of the peaks with P-values below 0.05
(Fig. 4c), suggesting the observed biogeographic feature was indeed
significant.
To determine the similarities and differences among the 6
anatomic regions, we carried out a permutation test [21]. Only the
significant P-values from this analysis were shown in Fig. 4d. No
significant difference was observed in any adjacent two regions.
However, we discovered significant differences between the
proximal colon (including cecum, ascending, transverse, and
descending colon), and the distal colon (including the sigmoid and
rectum). Notably, the transverse colon (the most central colonic
region) did not significantly differ with either proximal or distal
colonic regions.
Lastly, we noticed our analysis left 20% of the PC1 unexplained
by either individual or biogeographic effects. We speculated that it
might be a mixed contribution from other physiological factors,
such as age or gender. However, when tested in NLME or
permutation test, neither age nor gender reached statistical
significance, indicating that gender or age alone was not a
significant factor in determining the mucosal metaproteome. The
frequency plot of P-values for gender factor was shown as a
negative example (Fig. 4e).
Comparison of mucosal metaproteome and
transcriptome
We next sought to biochemically validate the bioinformatically-
defined biogeographic feature. To do so, we used a quantitative
shotgun proteomic methodology [22] to directly identify proteins
in sets of randomly selected individual samples from cecum,
Figure 2. Cellular and protein composition at the MLI. Upper panel: Cytology analysis of the cell pellet obtained from each mucosal lavage
sample using gram staining. a.1006b. 5006. Lower panel: Distribution of proteins with different origins identified from the mucosal lavage sample
using shotgun proteomic analysis. c. Composition of proteins from all species as identified by tandem MS. Other origin includes phage and
amoebozoa. d. Composition of bacterial proteins. Other bacterial origin includes Chlorobi and Cyanobacteria.
doi:10.1371/journal.pone.0026542.g002
Table 1. Summary of sample collection and clinical traits.
Total subjects 38
Total mucosal lavage samples 205
Gender Female 84 (41%)
Male 121 (59%)
Age Median ± SD 59610
Region Cecum 37 (18.0%)
Ascending 35 (17.1%)
Transverse 34 (16.6%)
Descending 38 (18.5%)
Sigmoid 31 (15.1%)
Rectum 30 (14.6%)
doi:10.1371/journal.pone.0026542.t001
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ascending colon, sigmoid, and rectum. As we expected, searches
against different protein databases identified both microbial and
human proteins. Here, we specifically focused on human proteins
since they have the richest annotation information for subsequent
analysis. In total, 31,224 spectra were collected and 300 human
proteins were identified. The complete protein list and the
spectrum count is organized into a spreadsheet (Dataset S2).
To determine the association of proteins isolated from colonic
lavage compared to cells from biopsied tissues, we annotated the
proteomic data in Scaffold using the latest protein information
available from UniproKB/Swiss-Prot database. Since high dimen-
sional proteomic datasets are not available from mucosal biopsy
samples, we used for comparison the mucosal transcriptome
recently reported as mRNA expression data for a large human
mucosal biopsy sample set [23], and annotated using GeneTools
[24]. Figure 5 shows the comparisons of the two datasets where the
proteome software has defined expressed product based on
‘‘biological processes’’, ‘‘cellular components’’, and ‘‘molecular
functions’’. For biological process annotations, proteins involved in
response to stimulus and immune system process were enriched in
Figure 3. Reproducibility of metaproteomic analysis. a. Steps for MALDI-TOF-MS data pre-processing. b. Scatterplot of two samples obtained
from the sample subject in adjacent colonic regions (sampling replicates). c. A representative 3D scatterplot of triplicate runs of the same sample
(technical replicates).
doi:10.1371/journal.pone.0026542.g003
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lavage samples compared to biopsies (Fig. 5a). For cellular
components, the extracellular protein segment was greatly enriched
in the lavage samples compared to biopsies as expected (Fig. 5b). For
the segments defined by molecular function, the identified
expression profile between the lavage samples and biopsies were
similar with the majority of the proteins/transcripts involved in
binding and catalytic activity (Fig. 5c).
Identifying specific proteins with biogeographic feature
For the 300 human proteins identified from lavage samples, we
used a stringent quality control protocol (described in Materials
and Methods) to filter out proteins with poor coverage or low
abundance. The ‘label-free spectrum counting’ method has been
adopted to quantify the relative abundance of protein in analyzing
shotgun proteomic data [22,25,26]. The Z-score transformed
relative abundance of each protein is presented in a heatmap
(Fig. 6), and the samples as well as the proteins were co-clustered
by Pearson correlations (Fig. 6). The sample tree was mainly
segregated into two large clusters with one outlier sample isolated
to the far left. The first cluster consisted of 7 proximal and 2
sigmoid samples, whereas the second cluster consisted of 5 distal
and 3 proximal samples. This suggested that the 49 proteins were
differentially detected in proximal and distal regions, further
confirming the biogeographic segmentation.
As shown in Figure 6 (brackets on the right-side y-axis), there
were a number of similar proteins that co-clustered. We selected
Figure 4. Features of humanmucosal metaproteome. a. PCA analysis revealed PC1 represents the largest component of the overall variance. b.
Variance component analysis showed variance in PC1 comes from both individual and biogeographic levels. c. Frequency plot of region-related P-
value for each peak from NLME analysis indicated a significant biogeographic feature. d. Frequency plot of gender-related P-value for each peak from
NLME analysis indicated no significance. e. Distal colon regions were significantly different from proximal regions in permutation analysis. Only
significant P-values (,0.05) were shown.
doi:10.1371/journal.pone.0026542.g004
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Figure 5. Comparison of lavage and biopsy samples by protein annotations. a. Biological process. b. Cellular component. c. Molecular
function.
doi:10.1371/journal.pone.0026542.g005
Protein Neighborhoods of the Mucosal Interface
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several of these proteins for individual analysis with regard to
biogeographical expression levels (Fig. 7). First, the immunoglob-
ulin-related proteins Ig gamma-1 chain C region (IGHG1), Ig
alpha-2 chain C region (IGHA2), Ig kappa chain V-III region VG
(KV309), and polymeric immunoglobulin receptor (PIGR) all
showed a similar pattern of lower expression in the proximal colon
compared to the distal colon (Fig. 7a and b). This is consistent with
the abundance of plasma cells and epithelial specialization for
immunoglobulin transcytosis at this anatomic location. Second, a
number of members of the elastase subfamily of serine hydrolases
Figure 6. Heatmap view of proteins identified by shotgun proteomics. Horizontal tree indicates 18 independent lavage samples. Vertical
tree indicates the 49 proteins analyzed, and the protein identities are listed on the right. Three of the proteins clusters showed biogeographic
features are bracketed.
doi:10.1371/journal.pone.0026542.g006
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[27] were identified and clustered. Three chymotrypsin-like
elastase family members 2A (CEL2A), 3A (CEL3A), 3B (CEL3B)
and chymotrypsin (CTRC) formed a tight cluster indicating a
similar expression pattern for the four proteins (Fig. 6). CEL3B
showed a particularly high level in the ascending colon, and then
declined gradually towards the distal regions (Fig. 7c). Conversely,
leukocyte elastase inhibitor (ILEU), the endogenous elastase
inhibitor [28], showed the lowest level in ascending and highest
in rectum colon (Fig. 7d). A third protein cluster was the meprin
family including two members meprin A subunit alpha (MEP1A)
and meprin A subunit beta (MEP1B). The relative levels of both
proteins were higher in proximal regions as compare to distal
regions (Fig. 7e and 7f). In addition, there were two other proteins
with low P-values as a biogeographic feature. Ectonucleotide
pyrophosphatase/phosphodiesterase family member 7 (ENPP7)
decreased from proximal to distal regions (Fig. 7g), yet
carcinoembryonic antigen-related cell adhesion molecule 5
(CEAM5) increased expression in these same regions (Fig. 7h).
In contrast to the foregoing, some known intestinal proteins
demonstrated no significant biogeographic features, including
mucin 2 (MUC2), trypsin-2 (TRY2), alpha-1-antitrypsin (A1AT),
carboxypeptidase A1 (CBPA1), carboxypeptidase B (CBPB1), and
intestinal-type alkaline phosphatase (PPBI) (Table S4).
Discussion
To understand the basic biology and investigate host-microbial
interaction at the human intestinal MLI, we used endoscopic
lavage as a straightforward but novel methodology to sample the
mucosal surface. This procedure involves minimal clinical risk,
and yields analytically reproducible samples composed of both
human and bacterial components expected at the MLI. Using
high-throughput MALDI-TOF-MS proteomics and a suite of
bioinformatics methods, we produced a high-dimensional dataset
containing both human and bacteria peaks, which we termed the
human mucosal metaproteome. Analysis of the mucosal metapro-
teome in healthy adults revealed substantial inter-individual
variation, but also revealed a significant biogeographic feature.
Furthermore, 49 distinct proteins were investigated in details in its
biogeographic feature, and 4 protein networks were identified.
These data suggest that MLI proteomics offer an informative,
integrative strategy for studying the human mucosal ecosystem.
A new way of viewing mucosal surface
Fecal or mucosal tissue biopsy samples are widely used in
human mucosal studies, but have certain limitations. Whereas the
fecal microbiota is a major biosynthetic and catabolic compart-
ment with local and systemic physiologic effects [5,6], it bears a
microbial composition distinct from that of the mucosal surface
[7,8,29], which instead is selected for adherence, host resistance,
and mucosal trophic factors. Also, fecal samples are a mixture of
products from all intestinal regions, which may obscure unique
host-bacteria interactions present at individual sites along the
mucosal interface [29]. Mucosal tissue biopsies are a useful
biospecimen for mucosal luminal interaction, but since they
require disruption of the mucosal barrier and are very small in
surface area, they are suboptimal for proteomic and other
functional analyses of the MLI. In comparison, mucosal lavage
sampling is appealing because it spares disruption of the mucosal
epithelium, permits repetitive sampling along the intestinal
anatomy, and is abundant in biochemical yield for analysis.
Recent studies have also shown that mucosal lavage yields robust
recovery of surface microbiota whose composition associates with
the host immunologic state and IBD disease state [30,31].
Shotgun proteomics demonstrated that mucosal lavage recov-
ered a diversity of both host and microbial proteins. With respect
to the host, the predominance of identified MLI proteins were
involved in binding and catalytic activity, comparable to a recent
analysis of the mucosal transcriptome [23]. As might be
anticipated, the MLI proteome was enriched compared to the
transcriptome for extracellular proteins, and these were predom-
inantly involved in response to stimulus and immune system
processes. With regard to the abundant microbiome detected
morphologically in the mucosal lavage specimens, it was surprising
that identifiable peptides were predominantly of human proteins
origin. However, shotgun proteomics preferably detects proteins
with relatively high abundance, and hence may under-detect
products from low frequency microbial taxa which in aggregate
account for most of the microbial population [7,8,9]. Also, there is
relatively incomplete documentation of bacterial proteins in the
current protein database, particularly for poorly characterized
taxa in the largely uncultured commensal microbiota. It is also
notable that the shotgun analysis only identifies proteins of the
microbes whose genomes have been sequenced and indexed in the
database. Therefore, it is likely that the contribution from
microbiota was underrepresented in our shotgun proteomic data.
Nevertheless, an interesting finding was the high number of
identifications for bacterial proteins from two-component signaling
systems. Two-component systems serve as a basic stimulus-
response coupling mechanism to allow organisms to sense and
respond to changes in many different environmental conditions
[32]. A published bioinformatics study of phylogenetic distribution
of nearly 5,000 histidine protein kinases from 207 sequenced
prokaryotic genomes suggested that this two-component signaling
system is crucial for the niche-adaption of bacteria [33]. Similarly,
competition in the intestinal habitat for Bacteroides thetaiotamicron is
exquisitely sensitive to the hybrid two-component system for
efficient glycan utilization [14]. In this study, we not only identified
proteins from Bacteroidetes, but also other bacterial phyla suggesting
a more comprehensive role of the two-component system in
intestinal microbiota.
Integration of bioinformatics and proteomics
High-resolution, high-throughput MS proteomics presents a
variety of challenges in data processing and analysis [16]. Without
careful design and analysis, the results and conclusions from high-
throughput proteomics can sometimes be misleading [18]. To
overcome the lack of mature, commercially-available data
management platforms, we established a unique data processing
pipeline for the high-resolution MALDI-MS data from inception
to final analysis. With regard to spectral data preprocessing
procedures (binning, deisotoping, baseline subtraction, peak
alignment, and intensity normalization), there are a variety of
algorithms [34,35,36,37,38,39,40] and software [17,41,42] avail-
able. For this study, we selected a recent edition of SpecAlign [17]
to process high-resolution spectrum data. In addition, we
developed a stringent quality control protocol to remove outlier
spectra. Consistent with other studies, we also found a batch effect
in our MALDI-MS experiments [18]. To address this, we adopted
an algorithm COMBAT [19,43] written in R, which successfully
corrected for the undesired batch effect before further analysis. We
not only tested the reproducibility and robustness of our sampling
strategy (sampling replicates), but also our working protocol
(technical replicates). The results showed that our protocol
includes all the important check-points for proteomic data
management, and consistently produced high-quality spectral
data for quantitative analysis. Since all the software and algorithms
used in our protocol are open source and readily accessible to the
Protein Neighborhoods of the Mucosal Interface
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public, we have tabulated the pipeline on our institutional website
for the convenience of other investigators.
Biogeographic features of mucosal metaproteome
A biogeographic feature of the microbiome [7] previously has
been described in healthy subjects. However, a systemic study of
the mucosa as an ecosystem at the colon surface has not yet been
reported. Using mucosal lavage sampling, each subject was
sampled 6 times at different colonic regions. The metaproteomic
data revealed both inter-individual variation, and also a significant
common biogeographic feature in the colon (distal versus proximal
colonic regions). Interestingly, no age or gender related feature was
observed. The distal colon is distinguished from more proximal
colonic regions by the distinctive ultrastructure in the epithelial
cells and the composition in the mucosal barrier [29,44]. In
addition, region-specific susceptibility is observed in ulcerative
Figure 7. Boxplots of representative proteins with biogeographic features. The bottom and top of the boxes are the 25th and 75th
percentile (the lower and upper quartiles, respectively), and the band near the middle of the box is the median. The whiskers present minimum to
maximum value in the group. CE: cecum. AS: ascending colon. SI: sigmoid colon. RE: rectal colon. ANOVA is used for comparison between different
regions. a. IGHA2 (P,0.001). b. KV309 (P,0.001). c. CEL3B (P = 0.017). d. ILEU (P = 0.017). e. MEP1A (P = 0.069). f. MEP1B (P = 0.044). g. ENPP7
(P = 0.014). h. CEAM5 (P,0.001).
doi:10.1371/journal.pone.0026542.g007
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colitis and colon cancer. Thus, the biogeographic metaproteome
may offer a functional counterpart to these distal colonic traits.
Quantitative shotgun proteomics established the identity and
confirmed the biogeographic association of 49 host proteins
demarcating the proximal and distal colon. These proteins
clustered into several functional protein networks, including:
immunoglobulin synthesis and transcytosis; the elastase subfamily
of serine hydrolases and their inhibitors; and, members of the
meprin metalloprotease family. Concordant with the latter
observation, mucosal mRNA levels of meprin-a and meprin-b
also decline from the proximal to distal colon. It is interesting to
note that MEP1A l (meprin A) is a susceptibility gene for ulcerative
colitis in human and immune colitis in mice [45]. In addition to
these networks of proteins, strong biogeographic distributions were
also observed for ENPP7 and CEAM5. ENPP7 is an ectoenzyme
with sphingomyelin-specific phospholipase C specificity, that is
released from the epithelial apical surface by luminal bile acid and
trypsin-like activity [27]. As in our study, it also shows a decreasing
expression gradient from ileum to distal colon [46], and has been
associated with inflammation and tumorigenesis [47,48,49].
CEAM5 is a member of the carcinoembryonic antigen (CEA)
family notable for epithelial cell adhesion and intracellular
signaling, and colorectal carcinogenesis [50,51,52,53]. CEAM5
mediates epithelial interaction with bacteria binding CEA-
associated glycans, and its rapid physiologic exfoliation is
considered a protective anti-microbial mechanism [54]. It is
possible that its elevated abundance in the distal colon may reflect
a role in interrupting bacterial intrusion in this region of
exceptional luminal bacterial load.
In summary, this paper has described and validated an
integrated proteomic approach that identifies functional features
of the human mucosal surface. These include impressive
distinctions between the proximal and distal colon, in accord with
the concept that these regions are functional and developmentally
distinct [55,56]. This analytic approach offers a new and robust
tool for understanding the basic biology and disease processes
involving the MLI.
Materials and Methods
Mucosal lavage sample collection
All enrolled subjects were consented with a valid IRB protocol,
and were prepared for colonoscopy by taking GolytelyH the day
before the procedure. During the colonoscopy procedure, 30 ml of
sterile 0.9% saline was injected to the surface of each of the six
different locations of the colon (cecum, ascending, transverse,
descending, sigmoid, and rectum) (Fig. 1). The mucosal lavage
samples were collected by vacuum suction with a Fujinon
magnifying colonoscope. Typically, 20 ml of saline was recovered
for each region. Lavage samples were kept on ice immediately
after collection, and then transferred to the UCLA High-
Throughput Clinical Proteomic Laboratory on the same day for
processing.
Cytology analysis
Mucosal lavage samples were spun at 1,0006g for 10 min to
form a cell pellet. Pellets were fixed and sectioned following a
standard cytology protocol by the UCLA Clinical Cytology
Laboratory, and sections were stained by either H&E or Gram
stain.
Shotgun proteomic analysis
The supernatant from each mucosal lavage sample was spun at
4,0006g for 30 min to remove solid components, and the clear
supernatant was transferred to a clean 50 ml tube, and acetone
added to the supernatant to precipitate proteins and peptides.
Samples were inverted several times to mix thoroughly and frozen
at 280uC overnight. The following day, samples were thawed and
spun down at 4,0006g for 30 min. The supernatant was
discarded, and the precipitated pellet was dried at room
temperature for 30 min. Each purified protein sample was
dissolved in 1 ml 25 mM Tris-HCl buffer pH 8 with 2 M Urea
by vortexing and pipetting. Samples were transferred to 2 ml
protein LoBind microcentrifuge tubes (Eppendorf, Hamburg,
Germany). The protein concentration of each combined sample
was quantified using the Bradford reagent. 5 ml of 1 M
dithiothreitol (DTT) was added to the remaining samples and
incubated in 37uC bath for 1 hour. 50 ml aliquots of 0.5 M
iodoacetamide (IAA) were added to the samples and incubated at
room temperature with rocking for 1 hour in aluminum foil. After
quenching with 10 ml of 1 M DTT and incubating at room
temperature for 30 minutes, the samples were diluted two-fold to
lower the DTT concentration. 10 mg of trypsin was added to each
sample and incubated in a 37uC bath overnight. Post-digestion
samples were run on a 4–18% Tris-Glycine gel to check the
digestion efficacy. The digested samples were then cleaned-up
through a 100 mg C18 cartridge (Alltech, Ontario, Canada), and
then resuspended in 24 ml of 2% methylnitrile with 0.1% TFA
solution. 10 ml of aliquots of each peptide sample was analyzed by
liquid chromatography tandem mass spectrometer (LC-MS/MS)
using an Eksigent autosampler coupled with Nano2DLC pump
(Eksigent, Dublin, CA) and LTQ-Orbitrap (Thermo Fisher
Scientific, Waltham, MA). The analytical column (10 cm675 mm
i.d.) contained 5 mm Integrafit Proteopep2 300 A˚ C18 (New
Objective, Woburn, MA). Peptides were eluted using a HPLC
gradient of 5% to 40% Buffer B in 45 min followed by a quick
gradient of 40% to 90% Buffer B in 10 min, where Buffer A
contains 0.1% formic acid in water and Buffer B contains 0.1%
formic acid in acetonitrile. Mass spectra were collected in positive
ion mode using the Orbitrap for parent mass determination and
the LTQ for data dependent MS/MS acquisition of the top 5 most
abundant peptides. MS/MS fragmentation spectra were searched
using SEQUEST (Version v.27, rev. 12, Thermo Fisher Scientific)
against the non-redundant Uniprot database indexed for human
and bacteria proteins. Search parameters included carbamido-
methyl cysteine (*C) as a static modification. Results derived from
database searching were filtered using the following criteria: Xcorr
.1.0(+1), 1.5(+2), 2(+3), and peptide probability score ,0.001,
and dCn .0.1 using Bioworks version 3.2 (Thermo Electron
Corp).
High-throughput MALDI-TOF-MS analysis and data
processing
To each precipitated protein sample, 500 ml of PBS with 1%
Triton-X was added and thoroughly mixed, and then transferred
to a 2 ml microcentrifuge tubes. Samples were centrifuged at
10,0006g and the supernatant was collected. The concentration of
each supernatant sample was determined by Bradford assay.
300 mg of total protein from each sample was diluted in PBS and
applied to subsequent analyses. Samples were then passed through
a 1-mm filter plate separately. 10 ml aliquots of the extracts were
mixed with 200 mg of weak cation exchange (WCX) magnetic
beads (MoBiTec, Goettingen, Germany) with 90 ml of 0.2 M
ammonium acetate pH 4.0 with 0.01% TX-100. The process has
been automated in a 96-well format with a Hamilton Starlet robot
(Reno, NV) where the beads are pelleted on a strong plate magnet
and washed 3 times. The beads were then desalted with 5 mM
ammonium acetate and extracted with 15 ml of 1% trifluoroacetic
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acid. 10 ml of the extracts were removed and mixed with an equal
volume of 5 mg/mL a-cyano-hydroxycinnamic acid matrix
(CHCA) dissolved in 90% acetonitrile. 2 ml each of the extract-
matrix mixture was then applied to a 96-well MALDI target in
triplicates. After drying, the plate was read in a Perkin-Elmer Sciex
prOTOF2000 reflectron mass spectrometer (San Jose, CA) with
settings for optimal detection of peptides and small proteins
between 2 and 20 kDa.
Since the samples were divided into 7 batches to complete the
MALDI analyses, the potential batch effects was addressed by
randomizing all samples, with each assigned an analysis date and
the position on MALDI plate. In addition, 5 ml aliquots from each
filtered sample were combined into a pooled sample, which was
analyzed in quadruplicate on each plate to serve as a batch control
of the inter- and intra-plate variation of MALDI analysis.
The pre-processing procedures are summarized in Fig. 3a.
MALDI data were exported using PG600 prOTOF Loader
software and cleaned in Python software using a homemade script.
This initial data cleaning step was critical to render the MALDI-
TOF-MS data accessible for the subsequent visualization and pre-
analytic processing in SpecAlign software (http://physchem.ox.ac.
uk/,jwong/specalign/index.htm). Each spectrum was first
trimmed to 2,000 to 20,000 m/z range, and binned at 0.25 m/z
window size to reduce the data dimension to a manageable size.
All spectra were then loaded simultaneously into SpecAlign.
Combining of all isotopic peaks was achieved by smoothing the
spectrum at 5 m/z window size twice. Baseline subtraction was
performed using 5 m/z window size. Stringent quality control
(QC) rules were applied to pick out spectra with poor qualities.
Each spectrum was inspected individually at two levels: total ion
intensity level and average correlation with the entire dataset.
Spectra with both intensity level and average correlation in the
bottom 20% of the spectral profiles were disqualified. The
remaining spectra were then normalized to total ion current
(TIC). Peaks were identified using criteria of signal threshold 0.5,
window size of 5 m/z, and signal-to-noise ratio of 1.5. Average
spectra of all technical replicates from the same sample were
produced in Python using a homemade script. All scripts are
downloadable from our laboratory website.
Quantitative shotgun analysis and data processing
Fifteen supernatant samples previously analyzed by MALDI-
MS were selected for quantitative shotgun analysis. It is the same
as described earlier with the exception of performing in-gel trypsin
digestion instead of in-solution. Briefly, 50 ug proteins of each
sample were loaded onto a NuPAGE 4–12% Bis-tris gel. The gel
was run at 100 V for about 15 minutes to allow the proteins to
migrate through the stacking portion of the gel. The entire lane
was excised, reduced with DTT, alkylated with IAA, and digested
with trypsin at a 1:50 ratio. We did notice that the in-gel digestion
greatly increased the efficacy of trypsin, and it was probably due to
inactivation of the trypsin inhibitor A1AT present at large amount
in the lavage samples.
All MS/MS spectra were then analyzed using Mascot (Version
2.2.2, Matrix Science, London, UK), and searched against the
SwissProt 57.15 database (selected for Homo sapiens only, 20266
entries). Mascot was searched with a fragment ion mass tolerance
of 0.40 Da and a parent ion tolerance of 10.0 PPM. Iodoaceta-
mide derivative of cysteine was specified in Mascot as a fixed
modification. Oxidation of methionine was specified in Mascot as
a variable modification. Scaffold (Proteome Software Inc., Port-
land, OR) was used to validate MS/MS based peptide and protein
identifications. Peptide identifications were accepted if they
exceeded specific database search engine thresholds. Mascot
identifications required at least ion scores must be greater than
both the associated identity scores and 20, 30, 40 and 40 for singly,
doubly, triply and quadruply charged peptides. Protein identifica-
tions were accepted if they contained at least 1 identified peptide.
Proteins that contained similar peptides and could not be
differentiated based on MS/MS analysis alone were grouped to
satisfy the principles of parsimony.
The following quality control criteria were further implemented
to select candidate proteins: 1) Minimal peptide hits had to be 2 for
each protein. 2) Sample U053 and U188 were removed as the
total spectrum counts were significantly lower than the others. 3)
Each protein had to be present in more than 50% of the samples.
49 proteins were filtered out for subsequent statistical analysis. The
label-free spectrum counting method was adopted to quantify the
relative abundance of protein in analyzing shotgun proteomic data
[22,25,26]. Normalization factor was calculated for each sample
by dividing the total spectrum counts by the average spectrum
counts. The spectrum count of a specific protein was multiplied by
the normalization factor to calculate the relative abundance. The
list of the normalized abundance and the P-values from ANOVA
for biogeographic effect of the 49 selected proteins is shown in
Table S4.
Statistics
All statistical analyses were conducted in R software (http://
www.r-project.org/). The averaged spectrum of each sample was
loaded into R. For the MALDI-MS data, Pearson correlation
coefficient was used to evaluate the batch effect, which was later
corrected using the COMBAT package [19,43]. Principal
Variance Component Analysis (PVCA) was used to calculate the
inter- and intra-subject variability in the metaproteome, and the
significance of the difference was further evaluated by permutation
test and NLME analysis. For permutation test, an average
spectrum for each region was calculated by averaging the intensity
of each peak within the same group, e.g. anatomic region, and
gender. The differences between two groups were measured by the
correlation coefficient between averaged spectra. The spectral data
was then permutated 1000 times, and the difference between two
groups was calculated after each permutation. The number of
distance smaller than the observed distance was divided by 1000 to
give the P-value of the specific group feature in examination. For
NLME analysis, the individual factor was set as the random effect
in the model, and the region, gender, and age were set as the fixed
effects. For the quantitative shotgun data, Z-score transformation
was carried out within each protein, and the normalized levels of
the 49 proteins identified were visualized in a heatmap with
hierarchical clustering. The P-value of the biogeographic feature
for each protein was calculated by ANOVA. All scripts written in
R are available from our laboratory website.
Supporting Information
Table S1 Proteins identified with shotgun proteomic analysis.
(RTF)
Table S2 Correlation matrix of the 28 quality control samples
from 7 batches.
(RTF)
Table S3 P-values of all protein/peptide features in the NLME
analysis.
(RTF)
Table S4 P-values of 49 proteins with biogeographic feature.
(RTF)
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Dataset S1 Metaproteome MALDI dataset containing relative
ion intensities of 438 peaks from 203 samples.
(CSV)
Dataset S2 Metaprotome shotgun dataset containing spectrum
counts of 300 proteins from 20 samples.
(CSV)
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